Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Enveric Biosciences Secures Key U.S. Patent to Broaden Neuropsychiatric Drug Pipeline
    1 January 2026

    Enveric Biosciences Secures Key U.S. Patent to Broaden Neuropsychiatric Drug Pipeline

    Enveric Biosciences, a biotechnology company developing next-generation small-molecule neuroplastogenic therapeutics, announced the issuance of a significant new U.S. patent that enhances its intellectual property portfolio and expands opportunities for advancing treatments in mental health disorders.
  • 1 January 2026
    Government bans high-dose Oral Nimesulide formulations in India
    The Central Government has officially banned the manufacture, sale, and distribution of all oral formulations containing nimesulide above 100 mg in immediate-release dosage form for human use across India.
  • 31 December 2025
    New Research Identifies Dihydrotanshinone I as a Potential Therapeutic Agent for Ovarian Cancer by Targeting SORT1

    A recent study published in Engineering has shed light on the potential therapeutic effects of dihydrotanshinone I (DHT), a compound derived from the traditional Chinese herb Salvia miltiorrhiza, on ovarian cancer. The research, conducted by a team from Zhejiang Chinese Medical University and Jiangsu Normal University, reveals that DHT can induce autophagic cell death in ovarian cancer cells by disrupting the sortilin 1 (SORT1)-mediated autophagy–lysosome pathway.

  • 30 December 2025
    Dr. Ruchi Sogarwal, Head Policy - Government Affairs, Danaher Corporation recognised among Top 10 Women Leaders in Business & Corporates

    Dr. Ruchi Sogarwal, a distinguished leader in public health and corporate affairs, Takeda Pharma, has been honoured with the Rajasthan WGA Award for Leadership in Corporates and recognised among the Top 10 Women Leaders in Business & Corporates. The award celebrates Rajasthan ki beti who have successfully broken barriers to reach leadership positions in national and global corporate leadership tables, inspiring the next generation of women leaders.

  • 27 December 2025
    Zydus Life sciences strategic partnership with Bioeq for NUFYMCO

    Bioeq AG, a Swiss biopharmaceutical company, and Zydus Lifesciences Limited , an innovation-led life-sciences company with an international presence, today announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE, United Arab Emirates has entered into a strategic partnership with Bioeq, for the licensing, supply and commercialization of Bioeq`s Vascular Endothelial Growth Factor (VEGF) inhibitor NUFYMCO®, an interchangeable biosimilar of Lucentis®1 (Ranibizumab) for the U.S. market. The Biologics License Application (BLA) for NUFYMCO® has been approved by U.S.

  • 26 December 2025
    New Global Study Questions Tramadol Use for Long-Term Pain Relief
    A new large systematic review published this week has raised important questions about the safety and effectiveness of tramadol, a widely prescribed opioid for chronic pain relief. The study, published online ahead of print in BMJ Evidence-Based Medicine, finds that while tramadol does reduce pain compared with placebo, the benefit is small and may not be clinically meaningful for many patients.
  • 26 December 2025
    Sanofi’s moves into adult Vaccines: Buying Dynavax in 2.2 billion USD
    In a strategic development that’s set to reshape its vaccine business, Sanofi has announced an agreement to acquire Dynavax Technologies Corporation, a U.S.-based vaccines company known for its marketed adult hepatitis B vaccine and an early-stage shingles vaccine candidate.
  • 26 December 2025
    New Hope for Thalassemia Patients as FDA Greenlights Agios’ Aqvesme – But Cautions Remain
    A major breakthrough for adults living with rare inherited blood disorders, the U.S. Food and Drug Administration (FDA) has officially approved Agios Pharmaceuticals’ oral drug AQVESME™ (mitapivat) for the treatment of anemia in both alpha- and beta-thalassemia, regardless of whether patients require regular blood transfusions or not.
  • 26 December 2025
    Biofabri–Bharat Biotech pact brings fresh hope in global fight against Tuberculosis
    Biofabri and Bharat Biotech International Limited have signed a technology transfer agreement aimed at improving worldwide access to the promising TB vaccine candidate, MTBVAC.
  • 24 December 2025
    New WHO Report Shows Big Gaps in Global Genomics Research
    The World Health Organization (WHO) has come out with a new global analysis that shows there are major equity gaps in human genomics research, especially between rich and poorer countries.
Subscribe to Pharma News